PT - JOURNAL ARTICLE AU - Walter, Katharine S. AU - Kim, Eugene AU - Verma, Renu AU - Altamirano, Jonathan AU - Leary, Sean AU - Carrington, Yuan J. AU - Jagannathan, Prasanna AU - Singh, Upinder AU - Holubar, Marisa AU - Subramanian, Aruna AU - Khosla, Chaitan AU - Maldonado, Yvonne AU - Andrews, Jason R. TI - Shared within-host SARS-CoV-2 variation in households AID - 10.1101/2022.05.26.22275279 DP - 2022 Jan 01 TA - medRxiv PG - 2022.05.26.22275279 4099 - http://medrxiv.org/content/early/2022/05/27/2022.05.26.22275279.short 4100 - http://medrxiv.org/content/early/2022/05/27/2022.05.26.22275279.full AB - Background The limited variation observed among SARS-CoV-2 consensus sequences makes it difficult to reconstruct transmission linkages in outbreak settings. Previous studies have recovered variation within individual SARS-CoV-2 infections but have not yet measured the informativeness of within-host variation for transmission inference.Methods We performed tiled amplicon sequencing on 307 SARS-CoV-2 samples from four prospective studies and combined sequence data with household membership data, a proxy for transmission linkage.Results Consensus sequences from households had limited diversity (mean pairwise distance, 3.06 SNPs; range, 0-40). Most (83.1%, 255/307) samples harbored at least one intrahost single nucleotide variant (iSNV; median: 117; IQR: 17-208), when applying a liberal minor allele frequency of 0.5% and prior to filtering. A mean of 15.4% of within-host iSNVs were recovered one day later. Pairs in the same household shared significantly more iSNVs (mean: 1.20 iSNVs; 95% CI: 1.02-1.39) than did pairs in different households infected with the same viral clade (mean: 0.31 iSNVs; 95% CI: 0.28-0.34), a signal that increases with increasingly liberal thresholds.Conclusions Although only a subset of within-host variation is consistently shared across likely transmission pairs, shared iSNVs may augment the information in consensus sequences for predicting transmission linkages.Competing Interest StatementThe authors have declared no competing interest.Funding StatementKSW received support from a Thrasher Early Career Award. Financial support from Stanford's Innovative Medicines Accelerator and operational support from Stanford ChEM-H is acknowledged.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The IRB of Stanford University School of Medicine gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSequence data is available at SRA (BioProject ID: PRJNA842503).